Suppr超能文献

生物活性重组人凝血因子VII在CHO-K1细胞中的表达及快速制备

Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.

作者信息

Xiao W, Li C Q, Xiao X P, Lin F Z

机构信息

Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, Sichuan, China.

出版信息

Genet Mol Res. 2013 Dec 16;12(4):6813-24. doi: 10.4238/2013.December.16.7.

Abstract

Human coagulation factor VII (FVII) plays an important role in the blood coagulation process and exists in micro amounts in human plasma; therefore, any attempt at the large-scale production of FVII in significant quantities is challenging. The purpose of this study was to express and obtain biologically active recombinant FVII (rFVII) from Chinese hamster ovary K1 (CHO-K1) cells. The full-length FVII cDNA was isolated from a HepG2 cell line and then subcloned in pcDNA3.1 to construct an expression vector, pcDNA-FVII. CHO-K1 cells were transfected with 1 µg pcDNA-FVII. The cell line that stably expressed secretory FVII was screened using 900 µg/mL G418. The FVII copy number in CHO-K1 cells was detected by quantitative polymerase chain reaction (qPCR). The rFVII was purified in ligand affinity chromatography medium. The purified protein was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis. The biological activity of the purified FVII protein was determined by a prothrombin time assay. Three cell lines that permanently expressed rFVII were screened. The qPCR results demonstrated that each CHO-K1 cell harbored two FVII DNA copies. The SDS-PAGE and Western blot analysis showed that the purified protein was about 50 kDa. The purity of the target protein was 95%. The prothrombin time assay indicated that the FVII-specific activity of rFVII was 2573 ± 75 IU/mg. This method enabled the fast preparation of high-purity rFVII from CHO-K1 cells, and the purified protein had good biological activity.

摘要

人凝血因子VII(FVII)在血液凝固过程中起重要作用,且在人血浆中微量存在;因此,任何大量大规模生产FVII的尝试都具有挑战性。本研究的目的是从中国仓鼠卵巢K1(CHO-K1)细胞中表达并获得具有生物活性的重组FVII(rFVII)。从HepG2细胞系中分离出全长FVII cDNA,然后亚克隆到pcDNA3.1中构建表达载体pcDNA-FVII。用1μg pcDNA-FVII转染CHO-K1细胞。使用900μg/mL G418筛选稳定表达分泌型FVII的细胞系。通过定量聚合酶链反应(qPCR)检测CHO-K1细胞中的FVII拷贝数。rFVII在配体亲和层析介质中纯化。纯化的蛋白质通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质免疫印迹分析进行检测。通过凝血酶原时间测定法测定纯化的FVII蛋白的生物活性。筛选出三个永久表达rFVII的细胞系。qPCR结果表明,每个CHO-K1细胞含有两个FVII DNA拷贝。SDS-PAGE和蛋白质免疫印迹分析表明,纯化的蛋白质约为50 kDa。目标蛋白的纯度为95%。凝血酶原时间测定表明,rFVII的FVII特异性活性为2573±75 IU/mg。该方法能够从CHO-K1细胞中快速制备高纯度的rFVII,且纯化的蛋白质具有良好的生物活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验